Nebius Group N.V. [NBIS] · Equity Underwriting Memo

Nebius Group N.V. [NBIS]

Price at publication
$169.72
Enterprise value
$43,140m
TTM revenue
$878.0m
EV / Sales
49.1x
Required revenue CAGR
143.8%
Demonstrated CAGR
NOT ESTIMABLE
Margin (demonstrated − required)
not computable
Exit multiple
4.5x (GROWTH_MATCHED)
12-month target
$118 - $227 (12-month, band; no defensible point estimate)
12-1 momentum percentile
97.8
Archetype
INFLECTION
Framework
Criteria, 2026-07-29

ANALYSIS, NOT A POSITION. Quality Criteria PASS on the INFLECTION standard (74% gross margin from the Q1'26 6-K; the us-gaap:GrossProfit tag does not exist, so the automated check correctly returns INDETERMINATE rather than FAIL - this name is calibration item D1's named case). Valuation Criteria FAIL: today's $43.1bn enterprise value requires a 143.8% revenue CAGR for five years, and the growth-matched exit multiple is UNIDENTIFIED because the only comparators bracketing its (artifactual) 239.8% growth are four sub-$100m shells. The required path stays above 67%/yr at every exit multiple up to 30x. Demonstrated CAGR is NOT ESTIMABLE - revenue ran $4,794m (2021, the old Yandex N.V.) to $14m (2022) after the Russian divestment, so the margin (demonstrated - required) cannot be computed and is reported as such rather than fabricated. 12-month target $118-$227 on consensus FY2027E revenue at 2.87x-5.50x EV/revenue; NBIS trades at 4.11x, a 43% premium to CoreWeave. Downside Criteria (MEASURED, blocks nothing): -94.9% at p=0.27, cause named as GPU residual value against a useful life lengthened from four years to five in Q1'26.

How to read this

This is an analysis, not a position. The memo scores every Criteria and blocks on none of them. Whether an analysis justifies a position is a question about a particular book, and two books answer it differently — so this page carries no Long, Short, Watchlist or Avoid verdict. The previous verdict has been retired.

Every Criteria returns PASS / FAIL / INDETERMINATE, and carries a type. BINDING criteria are admission tests for a long-only absolute-return strategy. MEASURED criteria are always scored and stored, and never block — they inform timing, sizing or a future strategy. A missing input is INDETERMINATE, never FAIL.

Two valuation outputs, over two horizons. The implied-path test (reverse DCF) asks what today's price requires over five years and whether the business has demonstrated it; the 12-month target asks what the name is likely to trade at, on near-term consensus and the name's own multiple history. Neither replaces the other. Sensitivity is run over the exit multiple, never over scenario probabilities.

Momentum is entry timing only. It governs when to enter a position the thesis already justifies, never whether to own one.

Key findings

Sections

Disclosed limitations